Pazopanib treatment outcome in advanced soft tissue sarcoma: Real-world data

被引：0
|
作者：
Alshamsan, B. [1 ]
Alshibany, A. [2 ]
Badran, A. [3 ]
Maraiki, F. [2 ]
Elshenawy, M. A. [4 ]
Elhassan, T. [2 ]
Atallah, J. P. [2 ]
机构：
[1] Qassim Univ, Dept Med, Coll Med, Qasim, Saudi Arabia
[2] King Faisal Specialist Hosp & Res Ctr, Ctr Canc, Med Oncol, Riyadh, Saudi Arabia
[3] Ain Shams Univ Hosp, Dept Clin Oncol, Ain Shams, Egypt
[4] Menoufia Univ, Fac Med, Clin Oncol, Shibin Al Kawm, Menoufia Govern, Egypt
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.1883
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1657P
引用
下载
收藏
页码：S987 / S987
页数：1
相关论文
共 50 条
  • [11] Real-world outcomes of pazopanib in metastatic soft tissue sarcoma: a retrospective Turkish oncology group (TOG) study
    Bilici, Ahmet
    Koca, Sinan
    Karaagac, Mustafa
    Aydin, Sabin Goktas
    Eraslan, Emrah
    Kaplan, Muhammed Ali
    Ocak, Birol
    Goksu, Sema Sezgin
    Paydas, Semra
    Akgul, Fahri
    Derin, Sumeyye
    Ergun, Yakup
    Yekeduz, Emre
    Erol, Cihan
    Ozyukseler, Deniz Tataroglu
    Demiray, Atike Gokcen
    Karaca, Mustafa
    Guc, Zeynep Gulsum
    Menekse, Serkan
    Cinkir, Havva Yesil
    Gumusay, Ozge
    Sakin, Abdullah
    Ozkul, Ozlem
    Demir, Hacer
    Erdem, Dilek
    Besiroglu, Mehmet
    Unal, Olcun Umit
    Acar, Ramazan
    Koral, Lokman
    Sahin, Suleyman
    Sakalar, Teoman
    Bahceci, Aykut
    Ozveren, Ahmet
    Gunaydin, Ulug Mutlu
    Seker, Mehmet Metin
    Sunar, Veli
    Dal, Pinar
    Artac, Mehmet
    Turhal, Serdar
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (11) : 8243 - 8253
  • [12] Olaratumab plus anthracyline in advanced/metastatic soft tissue sarcoma: Data of real-world utilization in Austria.
    Kocher, Florian
    Seeber, Andreas
    Weiss, Lukas
    Romeder, Franz
    Szkandera, Joanna
    Kuhr, Thomas
    Kostner, Susanne
    Pichler, Petra
    Jaeger, Thomas
    Greil, Richard
    Brodowicz, Thomas
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [13] Pazopanib for the treatment of soft-tissue sarcoma
    Heudel, Pierre
    Cassier, Philippe
    Derbel, Olfa
    Dufresne, Armelle
    Meeus, Pierre
    Thiesse, Philippe
    Ranchere-Vince, Dominique
    Blay, Jean Yves
    Ray-Coquard, Isabelle
    CLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2012, 4 : 65 - 70
  • [14] REAL-WORLD TREATMENT PATTERNS AND OUTCOMES FOR PATIENTS WITH ADVANCED SOFT TISSUE SARCOMA RECEIVING SYSTEMIC THERAPY IN BRAZIL
    Melo, A. C.
    Santi, P. X.
    Nunes, D. L.
    Aleixo, S. B.
    Martins, C. L.
    de Silva, A. V. T.
    Fernandez, F. L. C.
    Beato, P. M. M.
    Guimaraes, C. M.
    Oliveira, R. W.
    Silva Julian, G.
    Souza, H.
    Gatti de Menezes, F.
    Novick, D.
    VALUE IN HEALTH, 2019, 22 : S534 - S535
  • [15] Efficacy and safety of eribulin in the treatment of advanced adult soft tissue sarcoma (STS): First real-world data in Chinese population.
    Guo, Xi
    Zhou, Yuhong
    Zhuang, Rongyuan
    You, Yang
    Zhang, Chenlu
    Wang, Zhiming
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [16] Real-world data on the management of pazopanib-induced liver toxicity in routine care of renal cell cancer and soft tissue sarcoma patients
    Westerdijk, K.
    Krens, S. D.
    Steeghs, N.
    van der Graaf, W. T. A.
    Tjwa, E. T. T. L.
    Westdorp, H.
    Desar, I. M. E.
    van Erp, N. P.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2024, 93 (04) : 353 - 364
  • [17] Evaluating the Clinical Impact and Feasibility of Therapeutic Drug Monitoring of Pazopanib in a Real-World Soft-Tissue Sarcoma Cohort
    Meertens, Marinda
    Giraud, Eline L.
    van der Kleij, Maud B. A.
    Westerdijk, Kim
    Guchelaar, Niels A. D.
    Bleckman, Roos F.
    Rieborn, Amy
    Imholz, Alex L. T.
    Otten, Hans-Martin
    Vulink, Annelie
    Los, Maartje
    Hamberg, Paul
    van der Graaf, Winette T. A.
    Gelderblom, Hans
    Moes, Dirk Jan A. R.
    Broekman, K. Esther
    Touw, Daan J.
    Koolen, Stijn L. W.
    Mathijssen, Ron H. J.
    Huitema, Alwin D. R.
    van Erp, Nielka P.
    Desar, Ingrid M. E.
    Steeghs, Neeltje
    CLINICAL PHARMACOKINETICS, 2024, 63 (07) : 1045 - 1054
  • [18] Real-world data on the management of pazopanib-induced liver toxicity in routine care of renal cell cancer and soft tissue sarcoma patients
    K. Westerdijk
    S. D. Krens
    N. Steeghs
    W. T. A. van der Graaf
    E. T. T. L. Tjwa
    H. Westdorp
    I. M. E. Desar
    N. P. van Erp
    Cancer Chemotherapy and Pharmacology, 2024, 93 : 353 - 364
  • [19] Real-world evidence of the efficacy and tolerability of trabectedin in patients with advanced soft-tissue sarcoma
    de Sande Gonzalez, Luis Miguel
    Martin-Broto, Javier
    Kasper, Bernd
    Blay, Jean-Yves
    Le Cesne, Axel
    EXPERT REVIEW OF ANTICANCER THERAPY, 2020, 20 (11) : 957 - 963
  • [20] REAL-WORLD TREATMENT PATTERNS AND OUTCOMES FOR PATIENTS WITH ADVANCED SOFT TISSUE SARCOMA RECEIVING SYSTEMIC THERAPY IN THE UNITED KINGDOM
    Mytelka, D. S.
    Lorenzo, M.
    Stafkey-Mailey, D.
    D'yachkova, Y.
    Nagar, S. P.
    Candrilli, S. D.
    Kaye, J. A.
    VALUE IN HEALTH, 2016, 19 (07) : A751 - A751
12345